OQROGet OQRO Pro
Insider trade

Outset Medical (OM)General Counsel sold ~$9.5K

John L. Brottem, General Counsel at Outset Medical, sold ~$9.5K of Outset Medical shares.

~$9.5K
Approx. value · 2,842 sh @ $3.35
33K
Holds after · shares reported
Traded
Feb 17, 2026
Filed
Feb 20, 2026

The story around this disclosure

Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.

  1. Jan 7, 2026Company filing · Form 8-K · Results, Executive changeChanged a top executive or board member, and reported its results (and 1 more item)“On January 7, 2026, Andrea Saia, a member of the Company’s Board of Directors (the “Board”), stepped down from the Board, effective January 9, 2026. Ms. Saia’s resignation is not the result of any disagreement with the Company on any matter relating to the Company’s operations, policies or practices.”
  2. Jan 7, 2026Insider · 3 peopleInsiders: 3 sales (~$9K)
  3. Jan 20, 2026Insider · 3 peopleInsiders: 3 sales (~$136K)
  4. Jan 21, 2026Insider · 3 peopleInsiders: 3 sales (~$21K)
  5. Feb 11, 2026Company filing · Form 8-K · ResultsReported its results
  6. Feb 17, 2026 · this disclosureInsiderOfficer sold ~$9.5K of OM shares in the open market

What came next

  1. Feb 17, 2026Insider · 2 peopleInsiders: 2 sales (~$17K)
  2. May 7, 2026Company filing · Form 8-K · ResultsReported its results
  3. May 15, 2026Insider · 3 peopleInsiders: 3 sales (~$28K)
  4. May 26, 2026Company filing · Form 8-K · Executive changeChanged a top executive or board member“On May 26, 2026, Marc Nash informed Outset Medical, Inc. (the “Company”) of his decision to depart from the Company and his role as Executive Vice President, R&D, Operations and Service, effective June 5, 2026, to pursue other professional opportunities.”
  5. Jun 3, 2026InsiderCFO sold ~$87K of OM shares in the open market
  6. Jun 14, 2026Company filing · Form 8-K · Material agreement, ResultsSigned an important agreement, and reported its results
View the official recordSEC Form 4

How to read SEC Form 4

Form 4 is the filing that officers, directors and owners of more than 10% of a US-listed company must send to the SEC within two business days after they buy, sell or otherwise change their holding of the company's stock.

Full guide: What is an SEC Form 4?

What else is on file for Outset Medical

For Outset Medical, OQRO holds 5 insider filings (SEC Form 4 or Form 144) dated in the last 90 days.

These are records OQRO holds, counted by their date, not a measure of how much trading took place. Routine paperwork such as option exercises and tax withholding is left out. Everything for the company is on its OM page.

Other recent filings by John L. Brottem, General Counsel

The full history of John L. Brottem, General Counsel is on the profile page.

How this filing works

Other disclosures at Outset Medical

Everything OQRO holds on this company is on its OM page.

This is one filing. OQRO holds the rest

Insider trades filed with the SEC, stock trades disclosed by members of Congress, fund holdings from 13F filings and federal contract awards, each one in plain words next to its official filing. On this page it opens why the trade stands out, what the company did around that time, the price since, and every field of the form.

Unlock OQRO ProAlready have an account? Log in

OQRO Pro is a paid subscription. You see the price before you pay

OQRO describes public disclosures and context calculated from them. It does not give personalized advice and does not recommend any transaction. How OQRO treats data